Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5592218 | Molecular Immunology | 2016 | 15 Pages |
Abstract
We aimed to identify an optimum nano-carrier system to deliver tumor antigen to dendritic cells (DCs) for efficient targeting of tumor reinitiating cells (TRICs) in gynecological malignancies. Different lipid based nano-carrier systems i.e. liposomes, ethosomes and solid lipid nanoparticles (SLNPs) were examined for their ability to activate DCs in allogeneic settings. Out of these three, the most optimized formulation was subjected for cationic and mannosylated surface modification and pulsed with DCs for specific targeting of tumor cells. In both allogeneic and autologous trials, SLNPs showed a strong ability to activate DCs and orchestrate specific immune responses for targeting TRICs in gynecological malignancies. Our findings suggest that the mannosylated form of SLNPs is a suitable molecular vector for DC based therapeutics. DCs pulsed with mannosylated SLNPs may be utilized as adjuvant therapy for specific removal of TRICs to benefit patients from tumor recurrence.
Keywords
TNFCationic solid lipid nanoparticlesPBSTAATGFGM-CSFSPSFITCEthosomesimmunotherapyinterferonIFNanalysis of varianceANOVAcluster of differentiationDendritic cellsGranulocyte macrophage colony stimulating factortumor growth factortumor necrosis factorphosphate buffer salinelactate dehydrogenaseLDHLiposomesMHCNanoparticlesSolid lipid nanoparticlesNanomedicinepolymerase chain reactionPCRAntigenTranslational research
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Arpit Bhargava, Dinesh K. Mishra, Subodh K. Jain, Rupesh K. Srivastava, Nirmal K. Lohiya, Pradyumna K. Mishra,